Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program)

Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides and proteins replacement therapies, today announced new validating in vivo pharmacokinetic and ...

Mixing lab rigor with real life, researchers craft new recipe for groundbreaking alcohol studies

Nearly 80% of Americans aged 12 and older have consumed alcohol at least once in their lives, and 10% of the population ...

New technique lights up where drugs go in the body, cell by cell

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...
Le Lézard

FDA approves Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy® pill, the first oral GLP-1 medicine for obesity in the US.3 Wegovy® pill is used with a ...
GlobalSpec Insights

pH control in tissue culture: The key to cellular success

· Better growth, better results: Every cell type has its ideal pH — mammalian cells prefer about 7.4, while many plant cells ...